Singapore, June 26 -- Zydus Lifesciences and Sunshine Healthcare have announced the setting up of a strategic joint venture (JV) company - Zydus Sunshine Lifesciences, with an investment commitment of... Read More
Singapore, June 26 -- Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Addressing this concern, researchers at Hanyang University, South Korea, have developed an artificial ... Read More
Singapore, June 26 -- CStone Pharmaceuticals, a China-based biopharmaceutical company, has entered into an exclusive commercialisation agreement with Arrotex Pharmaceuticals, a core pharmaceutical com... Read More
Singapore, June 26 -- Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology company in Argentina, at the BIO International Convention 2026 i... Read More
Singapore, June 25 -- La Trobe University's Olga Tennison Autism Research Centre will receive $11.1 million over three years to establish the Australian Autism Knowledge Hub, as part of the Australian... Read More
Singapore, June 25 -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health - Abu Dhabi (DoH) has announced a collaborati... Read More
Singapore, June 25 -- China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea's Samsung Bioepis have announced the launch of the Samsung... Read More
Singapore, June 25 -- Healthcare systems across Southeast Asia are navigating a period of unprecedented change. Ageing populations, rising healthcare demands, workforce constraints and rapid technolog... Read More
Singapore, June 25 -- Ollin Biosciences has completed an oversubscribed US$330 million Series B financing to advance global Phase III development of OLN324, also known as IBI324, in retinal vascular d... Read More
Singapore, June 25 -- CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigational heart attack drug. The filing follows positive Phas... Read More